IP Group
Investor profile
IP Group has backed 24 European tech companies across 29 funding rounds between 2018 and 2026, joining rounds totalling €849M. Most active in Healthtech and Software. Data as of Nov 2026.
Deals
29
distinct rounds
Companies
24
backed
Active span
2018–2026
9 yrs
Total round €
€849M
sum of rounds joined
Deals by year
distinct rounds / yearIP Group — deals by year — interactive chart.
Data table
| IP Group — deals by year | |
|---|---|
| 2018 | 1 |
| 2021 | 4 |
| 2022 | 9 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 5 |
Top sectors
by dealsIP Group — top sectors — interactive chart.
Data table
| IP Group — top sectors | |
|---|---|
| Healthtech | 7 |
| Software | 5 |
| Cleantech | 5 |
| Robotics | 3 |
| Semiconductors | 3 |
| AI | 2 |
| Deeptech | 2 |
| Energy | 2 |
| Hardware | 1 |
| Transportation | 1 |
Stages
by dealsIP Group — stages — interactive chart.
Data table
| IP Group — stages | |
|---|---|
| Other | 14 |
| Series B | 6 |
| Series A | 4 |
| Seed | 2 |
| Series C | 2 |
| Series D+ | 1 |
Countries
by dealsIP Group — countries — interactive chart.
Data table
| IP Group — countries | |
|---|---|
| UK | 25 |
| Ireland | 2 |
| France | 1 |
| Germany | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Parkwalk Advisors10
- Hostplus4
- Tencent4
- Octopus Ventures3
- AlbionVC2
- BGF2
- Bloc Ventures2
- British Patient Capital2
- Cambridge Enterprise2
- Cambridge Innovation Capital2
- Flerie Invest2
- IQ Capital2
- Mercia Ventures2
- Oxford Science Enterprises2
- Oxford Technology and Innovations EIS Fund (OTIF)2
- Panakès Partners2
- Seventure Partners2
- Swisscom Ventures2
- UCL Technology Fund2
- Amadeus Capital Partners1
- Ananda Impact Ventures1
- AXA XL1
- Bits x Bites Growth Fund1
- Braavos Capital1
- Breakthrough Energy Discovery1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Oxford Nanopore Technologies | UK | 1 | €225M |
| Microbiotica | UK | 2 | €103M |
| Ultraleap | UK | 1 | €72M |
| Quantum Motion | UK | 1 | €48M |
| Ieso | UK | 1 | €47M |
| Bramble Energy | UK | 1 | €42M |
| moa Technology Limited | UK | 1 | €41M |
| First Light Fusion | UK | 1 | €40M |
| AccelerComm | UK | 2 | €38M |
| Mantle8 | France | 1 | €31M |
| Enterprise Therapeutics | UK | 1 | €30M |
| Oxbotica | UK | 1 | €16M |
| Slamcore | UK | 1 | €15M |
| Alesi Surgical | Ireland | 2 | €14M |
| DiffBlue | UK | 2 | €14M |
| MISSION Therapeutics | UK | 1 | €11M |
| Barocal | UK | 2 | €10M |
| GripAble | UK | 1 | €10M |
| Lumai | UK | 1 | €9.3M |
| Vytal | Germany | 1 | €9.1M |
| Deep Render | UK | 1 | €8.3M |
| Intrinsic | UK | 1 | €7.9M |
| Matter Machine | UK | 1 | €4.7M |
| Arkivum | UK | 1 | €1.7M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Oxford Nanopore Technologies | Other | €225M | 2021-05 |
| Ultraleap | Series D+ | €72M | 2021-11 |
| Microbiotica | Series B | €61M | 2022-03 |
| Quantum Motion | Series B | €48M | 2023-02 |
| Ieso | Series B | €47M | 2021-11 |
| Bramble Energy | Other | €42M | 2022-02 |
| moa Technology Limited | Series B | €41M | 2022-06 |
| First Light Fusion | Series C | €40M | 2022-02 |
| Mantle8 | Series A | €31M | 2026-05 |
| Enterprise Therapeutics | Series B | €30M | 2024-01 |